Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Chloranil | HCID 8371 | — |
| Reactant | tert-Butyl cyanoacetate | HCID 70693 | — |
| Reactant | Ammonium Acetate | HCID 517165 | — |
| Reactant | 1-(2-(Cyclopropylmethoxy)-6-(4-methoxybenzyloxy)phenyl)ethanone | HCID 9923379 | — |
| Reactant | 1-Boc-piperidine-3-carboxaldehyde | HCID 9964448 | — |
| Reactant | L-Ascorbic Acid | HCID 54670067 | — |
| Solvent | Ethyl Acetate | HCID 8857 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 10122432 | HCID 10122432 | — |
Reaction Steps
A mixture of 1-{2-(cyclopropylmethoxy)-6-[(4-methoxybenzyl)oxy]phenyl}ethanone (10.00 g, 30.638 mmol), tert-butyl 3-formyl-1-piperidinecarboxylate (13.069 g, 61.275 mmol), tert-butylcyanoacetate (8.650 g, 61.275 mmol), and ammonium acetate (6.902 g, 91.913 mmol) in dioxane (10 mL) was stirred at 90° C. overnight. After cooled to room temperature, the reaction mixture was diluted with ethyl acetate (100 mL). To the mixture was added chloranil (1.507 g, 6.128 mmol), and stirred at room temperature. After 1.5 hrs, ascorbic acid (1.079 g, 6.128 mmol) was added to the mixture. After stirred for 1.5 hrs, the mixture was partitioned between ethyl acetate and water. The organic phase was washed with brine, dried over MgSO4, filtered, and then concentrated under reduced pressure. The resulting residue was purified by column chromatography on Silica-gel (hexane/ethyl acetate=2/1) to give tert-butyl 2-amino-4-[1-(tert-butoxycarbonyl)-3-piperidinyl]-6-{2-(cyclopropyl-methoxy)-6-[(4-methoxybenzyl)oxy]phenyl}nicotinate as a pale brown form (4.9 g, 24%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07375103B2 |
|---|
| Source dataset | uspto-grants-2008_05 |
|---|
| ORD ID | ord-5af8908782c4416b99623b5301be832f |
|---|
| Source note | uspto-grants-2008_05 |
|---|